Neutropenia News and Research

RSS
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood.
FDA approves new treatment for people with hairy cell leukemia

FDA approves new treatment for people with hairy cell leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

FDA accepts Bristol-Myers Squibb’s application for Sprycel for treating pediatric leukemia

Researchers identify neutrophil progenitor in the bone marrow of mice and humans

Researchers identify neutrophil progenitor in the bone marrow of mice and humans

New personalized cellular therapy approved for use in the European Union

New personalized cellular therapy approved for use in the European Union

FDA approves first therapy for patients with rare tumors of the adrenal gland

FDA approves first therapy for patients with rare tumors of the adrenal gland

Pfizer announces FDA approval of biosimilar to Neupogen

Pfizer announces FDA approval of biosimilar to Neupogen

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

Researchers develop portable monitor to detect dangerous drop in white blood cells

Researchers develop portable monitor to detect dangerous drop in white blood cells

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Researchers explore targeted second-line treatment for colorectal cancer

Researchers explore targeted second-line treatment for colorectal cancer

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

Researchers aim to reveal new direction for Barth syndrome treatment

Researchers aim to reveal new direction for Barth syndrome treatment

Black patients found to be underrepresented in prostate cancer clinical trials

Black patients found to be underrepresented in prostate cancer clinical trials

FDA grants approval for first drug to treat inherited breast cancer

FDA grants approval for first drug to treat inherited breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label